Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
55.06
-5.54 (-9.14%)
At close: Nov 13, 2024, 4:00 PM
55.73
+0.67 (1.22%)
After-hours: Nov 13, 2024, 7:53 PM EST
Viking Therapeutics Employees
Viking Therapeutics had 27 employees as of December 31, 2023. The number of employees increased by 6 or 28.57% compared to the previous year.
Employees
27
Change (1Y)
6
Growth (1Y)
28.57%
Revenue / Employee
n/a
Profits / Employee
-$3,672,259
Market Cap
6.14B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 27 | 6 | 28.57% |
Dec 31, 2022 | 21 | 3 | 16.67% |
Dec 31, 2021 | 18 | -2 | -10.00% |
Dec 31, 2020 | 20 | 3 | 17.65% |
Dec 31, 2019 | 17 | -1 | -5.56% |
Dec 31, 2018 | 18 | 4 | 28.57% |
Dec 31, 2017 | 14 | 2 | 16.67% |
Dec 31, 2016 | 12 | 2 | 20.00% |
Dec 31, 2015 | 10 | 6 | 150.00% |
Jun 15, 2014 | 4 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Grifols | 23,737 |
Bausch + Lomb | 13,300 |
Elanco Animal Health | 9,800 |
RadNet | 8,441 |
Merit Medical Systems | 6,950 |
Legend Biotech | 1,826 |
Blueprint Medicines | 655 |
Cytokinetics | 423 |
VKTX News
- 1 day ago - Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024 - PRNewsWire
- 5 days ago - Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca - CNBC
- 9 days ago - Viking Therapeutics' Hot Stock Slips After Latest Obesity Drug Trial Results - Investopedia
- 9 days ago - Dow Jones, S&P 500 slip ahead of US elections; NVIDIA, Viking Therapeutics rise while Talen Energy declines - Invezz
- 9 days ago - Viking Therapeutics: Too Much Excitement Around Oral VK2735, Even If It Met High Expectations - Seeking Alpha
- 9 days ago - Viking Therapeutics Stock Swings Wildly After Weight-Loss Drug Data - Kiplinger
- 9 days ago - Viking Therapeutics' Reveals Early-Stage From Experimental Oral Obesity Drug Showing Weight Loss And Safety - Benzinga
- 9 days ago - Should you buy Viking Therapeutics (VKTX) after today's spike? - Invezz